Navigation Links
Published Study Shows VNUS ClosureFAST(TM) System Significantly Superior to Laser for Varicose Vein Treatment
Date:6/10/2009

Journal of Vascular & Interventional Radiology Cites Improved Recovery and Quality-of-Life with VNUS Technology

SAN JOSE, Calif., June 10 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a worldwide leader in medical devices for the minimally invasive treatment of venous reflux disease, announced today that the Journal of Vascular & Interventional Radiology, the prestigious monthly publication of the Society of Interventional Radiology, has published a study showing the VNUS ClosureFAST(TM) system for radiofrequency (RF) thermal ablation to be "significantly superior" to endovenous laser (EVL) for treating venous reflux, the underlying cause of symptomatic varicose veins.

The VNUS ClosureFAST catheter is a minimally invasive device generally used in the physician's office with a local anesthetic to heat and seal the great saphenous vein, the most common site of venous reflux in the leg. The RECOVERY trial was a multicenter, randomized, single-blinded study of 87 vein ablation procedures in 69 patients, comparing the ClosureFAST radiofrequency catheter to the 980 nm endovenous laser system. The study found that for all primary endpoints in the trial, the ClosureFAST radiofrequency catheter was statistically superior to laser treatment in providing a fast and comfortable recovery for the patient after treatment. Specifically, radiofrequency vein ablation'/>"/>

SOURCE VNUS Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
2. Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal Transfusion
3. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
4. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
5. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
6. Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs
7. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
8. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
9. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
10. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
11. Tumor Eradication Article Published by Cancer Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...EWYORK,Nov.25/PRNewswire/--Reportlinker.comannounc...logue: ,, MammographyEquipment-AGlobalMarketP...164330/Mammography-Equipment---A-Global-Market-Per...inindustrializedaswellasdevelopingnationsisaprinci...lobally,escalatingawarenessaboutbreastcancerhasall...
(Date:11/25/2009)...ALTHAM,Mass.,Nov.25/PRNewswire/--AccordingtoMillen...technologymarketintelligence,thenearly$3billionUSm...dgrowthoverthenextfiveyearsdespitetherecenteconomi...portfindsthatthismarketwillremainhighlydynamicover...izeddevicesinpreviouslyunderservedsegmentsofthetra...
(Date:11/25/2009)...EWYORK,Nov.25/PRNewswire/--Reportlinker.comannounc...logue: ,, PainManagement-GlobalTrends ,,...ment---Global-Trends.html ,, Widespreadavailab...cs,andtheadventofnewdrugshaveacceleratedthepaceofg...dreimbursementstructurecontinuetoshapedemandforser...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Carefxs New Referral Management Solution Increases Hospital Referral Volume Enhances Collaboration Among Specialists PCPs and Patients 54153 1Carefxs New Referral Management Solution Increases Hospital Referral Volume Enhances Collaboration Among Specialists PCPs and Patients 54153 2Carefxs New Referral Management Solution Increases Hospital Referral Volume Enhances Collaboration Among Specialists PCPs and Patients 54153 3Carefxs New Referral Management Solution Increases Hospital Referral Volume Enhances Collaboration Among Specialists PCPs and Patients 54153 4Health Market Science Announces Commercial Release of CompleteSpend V2 5 54151 1Health Market Science Announces Commercial Release of CompleteSpend V2 5 54151 2Health Market Science Announces Commercial Release of CompleteSpend V2 5 54151 3Rockport Healthcare Group Continues to Grow Coverage Area With New Work Comp Network Certification in Georgia 54149 1Rockport Healthcare Group Continues to Grow Coverage Area With New Work Comp Network Certification in Georgia 54149 2
...November 11, 2008 at 9:00 am ET, SOUTH SAN FRANCI...) today announced that the ACTIVE-1 Phase 3 trial,...icin, narrowly missed its,primary endpoint of redu...llowing bunionectomy surgery at four to 32 hours p...nt (p=0.004) from four to 48 hours,post-surgery. T...
...r,Pharmaceuticals Corp. ("Raptor" or the "Company"... the Company has entered into an agreement with,th...d,Angers") of France to,evaluate Raptor,s propriet...teamine") in a Phase II clinical trial in patients...,Angers has received a grant from the,Programme Ho...
Other Medicine Technology:Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring 2Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring 3Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring 4Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring 5Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 2Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 3Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 4Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 5Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 6
(Date:11/27/2009)... Multi-purpose bilingual colorin...ed for use by the business community to educate - ...subjects from Safety issues to Dinosuars to ABC,S ... Saint Louis, MO (PRWEB) November 27, 2009 -- ...onics or toys to keep them busy any hour of the da...
(Date:11/26/2009)... PRINCETON,N.J.,Nov.27/PRNewswire/--Thediabetespop...t25yearsandannualmedicalspendingonthediseaseisproj...dingtoastudypublishedintheDecemberissueof Diabetes...CDP),aprogramofNovoNordisk,commissionedtheanalysis...totheforecast,thenumberofAmericanslivingwithdiabet...
(Date:11/26/2009)...t a bigger thrill when on an emotional rollercoast...ealthDay News) -- Call it the fear factor meets th...hat spectators -- especially those who root for th...if it,s a closely contested match and victory was ...pair. , Chew on that this Thanksgiving weekend ...
(Date:11/26/2009)... Benton Communications announces...owth system for retailers struggling to make an ec...) November 26, 2009 -- Flu fears is the type of ch...e emergency room, according to Dr. David Benton, b...ased business growth system – The Rfactor I...
(Date:11/25/2009)... EMERYVILLE,Calif.,Nov.25/PRNewswire-FirstCall/-- ...ncedthatthecompanywillhosttwoinvestoreventsinDecem...9:00a.m.CT/10:00a.m.ET ,, Principalinvestigat...mibinrelapsedand/orrefractorymultiplemyeloma,asfea...alMeetingandExpositioninNewOrleans,LA.Theteleconfe...
Breaking Medicine News(10 mins):Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...unched to Provide Information and Product Acquisit...adlines of,the recent tragedies caused by Communit...g Solutions, LLC, part of the Key Medical Group of...ducts to combat and kill these superbugs. The webs...
...ld be part of routine medical care, researchers su...) -- Rates of HIV testing in the United States hav...d of all Americans ever having been screened for t... drug users -- have been tested within the past ye...
...Y and Southfield, MI October 23, 2007 The Juveni...st charitable funder of type 1 diabetes research, ...utical Research Laboratories (HPRL) to support the... , We are thrilled to be partnering with Housey P...
...bright Children,s Foundation is unveiling Get Fit,...nline program designed to reduce,obesity in teens ...ditions,such as blindness, amputation, renal failu...as they work to improve their,eating and exercise ...
...fits Market Experiences Largest Increase Since 199...cans received dental benefits than the year before...enefits enrollment, according to the 2007,Joint De...the top reason cited by consumers for not going to...
...-- Cancer therapies save and prolong many lives, b...a debilitating toll on patients, mental and emotio...ot dealt with during oncology treatment. Cancer c...ir ability to follow through on treatment, and fal...
Other Medicine News:Health News:Key Cleaning Solutions Products Utilized to Combat Community Acquired - MRSA (CA-MRSA) Are Succeeding In Killing Superbugs Where Normal Cleaning Practices and Products Are Not 2Health News:Key Cleaning Solutions Products Utilized to Combat Community Acquired - MRSA (CA-MRSA) Are Succeeding In Killing Superbugs Where Normal Cleaning Practices and Products Are Not 3Health News:Many at Risk for HIV Not Being Tested 2Health News:Many at Risk for HIV Not Being Tested 3Health News:JDRF partners with Housey Pharmaceutical Research Laboratories 2Health News:MultiVu Video Feed: STARLIGHT STARBRIGHT UNVEILS GET FIT, GET RIGHT A PROGRAM TO PREVENT TYPE 2 DIABETES AND WEIGHT-RELATED CONDITIONS IN TEENS 2Health News:Population Covered by Dental Benefits Increases 2Health News:Cancer care providers need to proactively address patients' psychological and social needs 2Health News:Cancer care providers need to proactively address patients' psychological and social needs 3
3M™ Precise™ Vista Disposable Skin Stapler
...he Eppendorf Reference Series 2000 Pipette is a sy...ompact and robust design, and superior operating c... to operate the measuring stroke and blow-out as w...pipette/tip" system ensures utmost accuracy and pr...
Pipetman F200
Ovation BioNatural Pipette, two-stroke, fixed volume, 100L
Medicine Products: